Phio Pharmaceuticals Corp. (PHIO)
↓ Download CSV- Sector Manufacturing
- Incorporated DE
- Fiscal year ends Dec 31
Key ratios (FY2025)
-43.2%
Return on equity
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | $0 | $21.0K | $138.0K | $15.0K | $19.0K |
| Operating Income | -$9.22M | -$7.39M | -$10.82M | -$11.46M | -$13.51M | -$8.79M | -$8.99M | -$7.36M | -$14.06M | -$9.02M |
| Net Income | -$8.70M | -$7.15M | -$10.83M | -$11.48M | -$13.29M | -$8.79M | -$8.91M | -$7.36M | -$12.45M | -$8.99M |
| EPS (Diluted) | $-1.45 | $-9.08 | $-46.76 | $-10.10 | $-12.43 | — | — | — | — | — |
| Total Assets | $21.49M | $5.74M | $9.36M | $12.81M | $25.17M | $15.74M | $8.04M | $15.32M | $4.10M | $13.40M |
| Total Liabilities | $1.34M | $1.01M | $1.63M | $1.97M | $3.24M | $2.72M | $2.29M | $1.74M | — | — |
| Shareholders' Equity | $20.15M | $4.72M | $7.73M | $10.84M | $21.93M | $13.02M | $5.75M | $13.58M | $1.83M | $10.86M |
| Cash & Equivalents | $21.03M | $5.38M | $8.49M | — | — | — | — | — | $3.58M | $12.91M |
| Operating Cash Flow | -$7.98M | -$7.11M | -$10.75M | -$12.13M | -$11.86M | -$8.80M | -$8.64M | -$7.52M | -$9.51M | — |
| Capital Expenditures | $12.0K | $1.0K | $5.0K | $121.0K | $51.0K | $19.0K | $72.0K | $5.0K | $203.0K | $4.0K |
| Shares Outstanding | 11.62M | 1.73M | 416.4K | 1.14M | 1.13M | 5.78M | 669.4K | 342.6K | 2.43M | 1.30M |